Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-11-04
1987-03-31
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549292, 514824, 560 56, 562466, C07D30930, A61K 31365
Patent
active
046543635
ABSTRACT:
Certain 6-(substituted-naphthyl)hydrocarbyl-4-hydroxytetrahydropyran-2-ones are unexpectedly potent in the treatment of familial hypercholesterolemia, hyperlipemia and atherosclerosis by virtue of their ability to inhibit the enzyme, 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase).
REFERENCES:
patent: 4248889 (1981-03-01), Oka et al.
patent: 4255444 (1981-03-01), Oka et al.
patent: 4262013 (1981-04-01), Mistui et al.
patent: 4375475 (1983-03-01), Willard et al.
Willard et al; CA 98:17922x (1983).
Dinner D. L.
DiPrima Joseph F.
Hollrah Glennon H.
Merck & Co. , Inc.
Sudol Michael C.
LandOfFree
Synthetic analogs of mevinolin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic analogs of mevinolin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic analogs of mevinolin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2213154